As the opioid crisis has evolved from prescription painkillers to illicit fentanyl, new data reveals that older adults are being affected more. Despite long being overlooked, this population is not ...
Among the flurry of executive orders (EOs) issued by President Trump as his first hundred days in office drew to a close are two taking aim at the high cost of prescription drugs. For many ideas in ...
President Trump’s strategy to lower prescription drug prices will be put to the test as drugmakers must now commit to the terms of his “Most Favored Nation” pricing plan or face unspecified actions ...
President Donald Trump today, Sept. 30, announced TrumpRX, a new website for Americans to buy drugs, while he touted lower prices across Pfizer drugs, according to the Wall Street Journal. Trump ...
WASHINGTON, Sept 29 (Reuters) - The number of people charged with breaking federal drug laws dropped to the lowest level in decades this year after the Trump administration ordered enforcement ...
Inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients while also showing potential against other respiratory infections. With its unique triple-action benefits, ...
It’s becoming increasingly clear that pharmaceutical companies can live with President Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices. The sector has long traded at a ...
This week, the Trump administration announced that the FDA had approved leucovorin, a generic drug, as a treatment for autism. The announcement shocked health experts because the FDA’s usual approval ...
President Donald Trump announced a new round of tariffs beginning in October 2025 that would impose a 100% duty on brand name drugs imported to the United States. There's a major exemption to the ...
WASHINGTON (AP) — When President Donald Trump’s administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts — including the ...
Infection rates from “nightmare” drug-resistant bacteria have skyrocketed in the United States, scientists warned this week. Cases of patients infected with the gnarly bacteria rose an alarming 70% ...
Shares of Tylenol-maker Kenvue jumped more than 6% as trading opened Tuesday, a day after President Donald Trump linked the use of the drug’s active ingredient during pregnancy to increased risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results